A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

Recently, many people have learned about semaglutides and the good they're doing for diabetes and obesity. Medications like Ozempic, Wegovy, Mounjaro, and Rybelsus have received widespread attention, ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Robert F. Kennedy Jr., President Trump’s nominee for health secretary, doesn’t just hold fringe views on vaccines. We ...

A diagnosis of gestational diabetes can add to the worry and stress of any pregnancy. Diabetes educator Annie Reed emphasizes ...

The FDA's approval is based on the results of the FLOW phase 3b kidney outcomes trial. The trial revealed that Ozempic® 1 mg significantly lowered the relative risk of worsening kidney disease, kidney ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

A positive response to treatment for pediatric obesity has enduring health benefits into young adulthood, according t ...